These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 318920)

  • 21. Cataracts in rats given a bladder carcinogen, N-butyl-N-(4-hydroxybutyl)-nitrosamine.
    Fujita J; Yoshida O; Fujita H; Mikuni I
    Tokai J Exp Clin Med; 1983 Nov; 8(4):359-63. PubMed ID: 6679940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in dogs.
    Okajima E; Hiramatsu T; Hirao K; Ijuin M; Hirao Y; Babaya K; Ikuma S; Ohara S; Shiomi T; Hijioka T; Ohishi H
    Cancer Res; 1981 May; 41(5):1958-66. PubMed ID: 7214364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aging and urinary bladder carcinogenesis induced in rats by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Fukushima S; Shibata M; Tamano S; Ito N; Suzuki E; Okada M
    J Natl Cancer Inst; 1987 Aug; 79(2):263-7. PubMed ID: 3474459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trisodium nitriloacetate monohydrate: promoting effect in urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Hiasa Y; Kitahori Y; Konishi N; Shimoyama T; Miyashiro A
    J Natl Cancer Inst; 1985 Jan; 74(1):235-9. PubMed ID: 3855482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative carcinogenicity of N-butyl-N-(3-carboxypropyl)-nitrosamine and N-butyl-N-(4-hydroxybutyl)nitrosamine for the urinary bladder of (C57BL/6 X DBA/2)F1 mice.
    Irving CC; Murphy WM; Daniel DS
    J Natl Cancer Inst; 1984 Sep; 73(3):753-6. PubMed ID: 6590920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concanavalin A agglutination of bladder cells of rats treated with bladder carcinogens; a rapid new test to detect bladder carcinogens.
    Kakizoe T; Kawachi T; Okada M
    Cancer Lett; 1978 Nov; 5(5):285-90. PubMed ID: 728886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carcinogenicity and mutagenicity of N-nitroso compounds.
    Lijinsky W
    Mol Toxicol; 1987; 1(1):107-19. PubMed ID: 3329700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship of urinary N-butyl-N-(3-carboxypropyl)nitrosamine to susceptibility of animals to bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Suzuki E; Mochizuki M; Okada M
    Gan; 1983 Jun; 74(3):360-4. PubMed ID: 6884694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid assay of N-butyl-N-(3-carboxypropyl)nitrosamine in rat organs and urine by high-performance liquid chromatography after derivatization.
    Wada S; Funae Y; Imaoka S; Kawamura M; Kinoshita Y; Sugimoto T; Nishio S; Kishimoto T; Maekawa M
    Jpn J Cancer Res; 1985 Mar; 76(3):192-6. PubMed ID: 3922837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soft agar colony formation of bladder cells during carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine and application to detection of bladder cancer promoters.
    Hashimura T; Kanamaru H; Yoshida O
    Jpn J Cancer Res; 1987 May; 78(5):473-9. PubMed ID: 3112059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder cancer in C57BL/6 X DBA/2 F1 mice as a useful model for study of chemoprevention of cancer with retinoids.
    Becci PJ; Thompson HJ; Strum JM; Brown CC; Sporn MB; Moon RC
    Cancer Res; 1981 Mar; 41(3):927-32. PubMed ID: 7459879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose response of saccharin in induction of urinary bladder hyperplasias in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Nakanishi K; Hagiwara A; Shibata M; Imaida K; Tatematsu M; Ito N
    J Natl Cancer Inst; 1980 Nov; 65(5):1005-10. PubMed ID: 6933236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha-hydroxylation and mutagenicity of unsymmetrical N-nitrosodialkylamines with a butyl group.
    Suzuki E; Mochizuki M; Takeda K; Okada M
    Jpn J Cancer Res; 1985 Mar; 76(3):184-91. PubMed ID: 3922836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of action of the urinary bladder carcinogen N-nitrosobutyl-3-carboxypropylamine.
    Janzowski C; Jacob D; Henn I; Zankl H; Pool-Zobel BL; Wiessler M; Eisenbrand G
    IARC Sci Publ; 1991; (105):332-8. PubMed ID: 1855875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of tumors in heterotopic bladder by topical application of N-methyl-N-nitrosourea and N-butyl-N-(3-carboxypropyl)nitrosamine.
    Oyasu R; Iwasaki T; Matsumoto M; Hirao Y; Tabuchi Y
    Cancer Res; 1978 Sep; 38(9):3019-25. PubMed ID: 679209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic fate of N-n-butyl-N-(4-hydroxybutyl)-nitrosamine and its analogues. Selective induction of urinary bladder tumours in the rat.
    Okada M; Ishidate M
    Xenobiotica; 1977; 7(1-2):11-24. PubMed ID: 191997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory effect of 13-cis-retinoic acid on urinary bladder carcinogenesis induced in C57BL/6 mice by N-butyl-N-(4-hydroxybutyl)-nitrosamine.
    Becci PJ; Thompson HJ; Grubbs CJ; Squire RA; Brown CC; Sporn MB; Moon RC
    Cancer Res; 1978 Dec; 38(12):4463-6. PubMed ID: 719631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutagenic and cell-transforming activities of triol-epoxides as compared to other chrysene metabolites.
    Glatt H; Seidel A; Bochnitschek W; Marquardt H; Marquardt H; Hodgson RM; Grover PL; Oesch F
    Cancer Res; 1986 Sep; 46(9):4556-65. PubMed ID: 3524815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of an experimental model for studying bladder carcinogen metabolism using the isolated rat urinary bladder.
    Airoldi L; Bonfanti M; Magagnotti C; Fanelli R
    Cancer Res; 1987 Jul; 47(14):3697-700. PubMed ID: 3594434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strong promoting activity of reversible uracil-induced urolithiasis on urinary bladder carcinogenesis in rats initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Shirai T; Tagawa Y; Fukushima S; Imaida K; Ito N
    Cancer Res; 1987 Dec; 47(24 Pt 1):6726-30. PubMed ID: 3677102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.